Growth • Catalyst Pharmaceuticals
CPRX
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
36,9%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
43,7%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
38,7%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
34,3%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
33,6%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
47,3%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!